HCP educational resource
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data
The upfront combination lipid-lowering therapy is superior to statin monotherapy for all-cause mortality in patients with ACS. These results suggest that in high-risk patients, such an approach, rather than a stepwise therapy approach, should be recommended.
Sign in to open this educational resource.
This resource is available to healthcare professionals. Verify your profile to open the material, its clinical evidence and the accompanying resource file.
01Sign in or create your HCP account.
02Complete professional verification.
03Access approved HCP information.